Name
Osaühing Salvare Apteek
Registry code
10200510
VAT number
EE100665141
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
27.05.1997 (27)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
47731 - Dispensing chemist in specialised stores
448 332 €
5 767 €
1%
1 235 €
(estimate is approximate)
49 306 €
1
Submitted
No tax arrears
12%
7%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Heli Mark 02.06.1957 (67) | 100% - 2 556.00 EUR | Board member | Direct ownership | |
| Taavi Mark 07.05.1983 (41) | - | Board member | - |
| 2019 16.06.2020 | 2020 08.06.2021 | 2021 16.06.2022 | 2022 15.05.2023 | 2023 27.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 177 034 € | 262 348 € | 336 542 € | 398 298 € | 448 332 € |
| Net profit (loss) for the period | 2 871 € | 10 348 € | 7 261 € | 1 769 € | 5 767 € |
| Profit Margin | 2% | 4% | 2% | 0% | 1% |
| Current Assets | 38 626 € | 46 025 € | 47 543 € | 69 051 € | 84 339 € |
| Fixed Assets | 0 € | 0 € | 0 € | 0 € | 0 € |
| Total Assets | 38 626 € | 46 025 € | 47 543 € | 69 051 € | 84 339 € |
| Current Liabilities | 14 465 € | 11 516 € | 5 773 € | 25 512 € | 35 033 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 24 161 € | 34 509 € | 41 770 € | 43 539 € | 49 306 € |
| Employees | 1 | 1 | 1 | 1 | 1 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 127 641.98 € | 5 626.37 € | 1 946.67 € | 1 |
| 2023 Q4 | 103 046.38 € | 4 710.44 € | 1 975.47 € | 1 |
| 2023 Q3 | 135 874.92 € | 3 100.92 € | 1 975.47 € | 1 |
| 2023 Q2 | 107 682.36 € | 2 508.7 € | 1 958.07 € | 1 |
| 2023 Q1 | 73 845.6 € | 2 586.5 € | 1 946.98 € | 1 |
| 2022 Q4 | 105 380.45 € | 2 582.9 € | 1 933.84 € | 1 |
| 2022 Q3 | 70 902.51 € | 4 168.77 € | 1 994.4 € | 1 |
| 2022 Q2 | 109 241.43 € | 4 494.36 € | 1 794.4 € | 1 |
| 2022 Q1 | 92 518.48 € | 2 748.37 € | 1 694.4 € | 1 |
| 2021 Q4 | 114 391.15 € | 2 681.66 € | 1 694.4 € | 1 |
| 2021 Q3 | 87 551.49 € | 2 484.29 € | 1 709.76 € | 1 |
| 2021 Q2 | 74 381.28 € | 2 441.01 € | 1 740.48 € | 1 |
| 2021 Q1 | 61 887.93 € | 2 661.71 € | 1 740.48 € | 1 |
| 2020 Q4 | 61 503.22 € | 2 512.03 € | 1 740.48 € | 1 |
| 2020 Q3 | 69 740.54 € | 2 593.77 € | 1 740.48 € | 1 |
| 2020 Q2 | 74 128.24 € | 2 384.61 € | 1 740.48 € | 1 |
| 2020 Q1 | 52 905.15 € | 2 536.03 € | 1 740.48 € | 1 |
